Latest indication allows clinicians to leverage the accuracy, precision, and intraoperative flexibility of robotic assistance when performing alveoloplasty – a key phase of many full-arch cases
Neocis, manufacturer of Yomi and the global leader in robot-assisted dental surgery, announced the official market launch of the platform’s bone reduction module. Cleared by the U.S. Food and Drug Administration (FDA) in November of 2022, this latest offering from Neocis enables dental professionals to use Yomi to precisely plan bone reduction (using a patient’s CT scan) and then execute the treatment plan with the help of robotic guidance.
AiThority Interview Insights: AiThority Interview with Joshua Wilson, Commercial Director, JAPAC at Crimtan
Yomi, the first and only FDA-cleared robotic system for dental surgery, assists clinicians in planning and operative phases of dental implant placement via interactive digital planning (using YomiPlan™ software) and haptic guidance of surgical instrumentation. The Yomi platform, which received a prized Cellerant Best of Class Technology Award last summer, has helped general dentists and specialists place more than 28,000 implants and perform upwards of 16,000 robot-guided cases. Every ten minutes a dental implant is placed robotically, according to current data from Neocis.
Alveoloplasty is a common dental procedure during which the surface of a patient’s alveolar bone is reshaped and reduced to prepare a foundation for a full-arch restoration. Achieving a smooth, level ridge with enough room for a prosthesis contributes to predictable, long-lasting outcomes. Yomi’s bone reduction module, Neocis’ 14th FDA clearance, is designed to help clinical teams throughout the planning and intraoperative phases of this procedure, so they can perform complex full-arch cases with confidence and efficiency.
“I’ve been doing full-mouth reconstruction for a long time, and I can say that Yomi takes bone reduction to the next level,” said Dr. Sanju Jose, a periodontist in the Baltimore-Washington metropolitan area and one of the first clinicians in the country to use this new feature in a live surgical setting. “After just a few cases, I knew this functionality would be a game-changer for us. Every time my team uses Yomi for ridge reduction, we look at each other and say, ‘this is amazing.’”
Read More about AiThority Interview: AiThority Interview with Rick Farnell, Chief Executive Officer of Tracer
Robot-guided alveoloplasty is a novel approach that avoids some of the drawbacks associated with traditional surgical methods. Yomi physically prevents the user from moving the cutting bur beyond the precise reduction boundaries defined in the treatment plan and provides a clear virtual reference of how much bone has been removed. Unlike physical guides, robotic assistance enables intraoperative treatment modifications, allows for unobstructed visualization, irrigation, and palpation of the surgical site, and doesn’t require the clinician to reflect large flaps, which helps maintain blood supply to the bone.
“Yomi saves me a bunch of time by allowing me to precisely plan every dimension of the reduction volume for each patient,” said Dr. Scott Clayhold, an oral and maxillofacial surgeon in the Seattle area. “Then, I have the clinical flexibility to take the bur where I want, knowing that Yomi will prevent me from going beyond the boundaries I’ve set in my plan. That’s the beauty of robot-guided surgery.”
Latest AiThority Interview Insights : AiThority Interview with Oji Udezue, Chief Product Officer at Typeform
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.